Goldman Sachs Alternatives is a private equity firm1.
It has taken part in 2 funding rounds across 2 Israeli companies, leading 22,1.
Most recent: Cyera’s Series D+ of $400M2, announced Sep 22, 2026.
Israeli rounds
| Sep 22, 2026 | Cyeracybersecurity, data | Series D+ | $400M | Lead |
| Apr 29, 2026 | Aidochealthtech, ai | Growth | $150M | Lead |
Israeli portfolio
Who invests alongside Goldman Sachs Alternatives?
Sources
- 1CTech, Apr 29, 2026. “Aidoc raises another $150 million to advance AI in clinical decision-making | CTech”
- 2Calcalist (CTech), Sep 22, 2026. “Cyera raises $400 million from Goldman Sachs, bringing 2026 funding to $1.4 billion”
Which Israeli startups has Goldman Sachs Alternatives invested in?
Goldman Sachs Alternatives has invested in Cyera and Aidoc.
How many rounds has Goldman Sachs Alternatives led?
Goldman Sachs Alternatives led 2 rounds of the 2 rounds it joined.
What was Goldman Sachs Alternatives’s most recent Israeli investment?
Cyera’s Series D+ of $400M, announced Sep 22, 2026.